Forštnarič, A. et al. 2026. Balancing the Benefits and Risks of SGLT2 Inhibitors: Koristi in pasti zdravljenja s SGLT-2 zaviralci. Acta Medico-Biotechnica. 19, 1 (Jun. 2026), 10–17. DOI:https://doi.org/10.18690/actabiomed.300.